Arcturus Therapeutics Holdings Inc
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -6.2% | -2.5% | -7.2% | -4.6% | -7.2% | -3.6% | -6.8% | -8.7% | -4.0% | -9.5% | -8.6% | |
| – | -1.7% | -2.8% | -7.7% | -4.7% | -7.5% | -8.9% | -1.5% | -9.2% | -3.1% | -10.2% | -9.1% | |
| – | -6.4% | -1.2% | +9.3% | -24.8% | -0.1% | -8.5% | -9.4% | -8.2% | +28.0% | -8.5% | -9.4% | |
| – | -6.4% | -1.2% | +9.3% | -24.8% | -0.1% | -8.5% | -9.4% | -8.2% | +28.0% | -8.5% | -9.4% | |
| – | -16.1% | -15.6% | -11.0% | +25.4% | -86.8% | +266.7% | +18.1% | -53.8% | -30.0% | -75.9% | +35.0% | |
| – | -100.0% | +5,499,999,900.0% | -100.0% | – | – | – | – | – | – | – | – | |
| – | -15.0% | +2.6% | -16.0% | -16.3% | -5.2% | -4.9% | -20.2% | -26.1% | -1.1% | -5.4% | -2.9% | |
| – | -6.5% | +40.8% | -20.5% | -24.3% | -5.7% | -24.6% | -5.9% | -31.9% | +14.8% | -5.5% | -2.4% | |
| – | +2.6% | -0.9% | -8.3% | -12.3% | +3.4% | +3.4% | +9.8% | +2.3% | +2.2% | +2.2% | -7.9% | |
| – | -71.3% | +73.2% | +52.1% | -27.1% | -29.0% | -14.1% | +71.9% | -48.3% | -22.9% | -3.4% | +7.8% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -0.6% | -5.2% | -2.0% | +1.3% | -8.0% | -3.0% | -1.2% | -2.8% | -4.7% | -10.6% | -10.2% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.2% | +0.9% | +0.3% | +0.4% | -0.2% | +0.4% | +0.1% | +0.2% | +0.7% | +3.8% | +0.0% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.